University of Washington

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).

1,048 total trials 156 currently recruiting 720 completed early-phase tilt top decile by trial count

University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.

University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.

Top-decile sponsor footprint

University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,048 total, page 12 of 21

COMPLETED NA

APOE Genotype and Diet Influences on Alzheimer's Biomarkers

NCT03070535
COMPLETED

Pocket Phantom Tool in Improving Accuracy of Quantitative PET/CT Imaging of Patients With Solid Tumors

NCT02822365
COMPLETED NA

Beliefs and Attitudes for Successful Implementation in Schools (BASIS)

NCT03791281
COMPLETED NA

Apical Size and Root Canal Treatment Success Trial (AS-RCT Trial)

NCT03053037
TERMINATED Phase 4

Genetic and Dietary Predictors of Anti-platelet Response

NCT04456608
COMPLETED NA

Tethered Capsule Endoscope in Screening Patients With Barrett Esophagus

NCT02729948
COMPLETED Phase 4

Effects of Isotretinoin on CYP2D6 Activity

NCT03076021
COMPLETED NA

Short-Term Exposure for PTSD

NCT02874898
COMPLETED NA

Stroke and CPAP Outcome Study 2

NCT02809430
COMPLETED NA

Computerized DBT Skills Training for Suicidal and Heavy Episodic Drinkers

NCT02932241
COMPLETED Phase 3

American Trial Using Tranexamic Acid in Thrombocytopenia

NCT02578901
COMPLETED NA

Addressing Microaggressions in Racially Charged Patient-provider Interactions: A Pilot Randomized Trial

NCT04180956
COMPLETED Phase 2

FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging

NCT02773238
COMPLETED Phase 1

Nicotinamide Riboside in Systolic Heart Failure

NCT03423342
COMPLETED NA

A Hybrid Effectiveness-Implementation Trial of a School-Based Teen Marijuana Checkup

NCT03111667
COMPLETED Phase 1

Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab

NCT00194714
COMPLETED NA

The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial

NCT02800785
COMPLETED NA

Study of Team Leadership Training Effect on Patient Care

NCT03155490
COMPLETED NA

PainTracker Self-Manager: a Web-based Platform to Promote and Track Chronic Pain Self-management

NCT03045081
COMPLETED NA

Helping Individuals With Firearm Injuries

NCT02630225
COMPLETED NA

Community Walking Trials: Comparing Prosthetic Feet

NCT03703232
COMPLETED Phase 4

Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity

NCT02432404
COMPLETED Phase 2

A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)

NCT02354859
COMPLETED

DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory

NCT02776787
TERMINATED Phase 1

Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

NCT02565901
COMPLETED Phase 2

Trial of Oral Glutamine on Mitochondrial Function in CKD

NCT02838979
COMPLETED

Safer Conception Intervention for HIV-1 Serodiscordant Couples

NCT03030768
COMPLETED Phase 4

Immune Response to Shingles Vaccination

NCT02624375
COMPLETED Phase 4

Copper IUD Treatment Observation Study

NCT02519231
COMPLETED Phase 2

Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients

NCT02615197
COMPLETED Phase 2

Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

NCT02598895
COMPLETED Phase 4

Incidence and Severity of Residual Neuromuscular Blockade

NCT02660398
COMPLETED Phase 1

Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer

NCT02532114
COMPLETED NA

Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children

NCT02650583
COMPLETED

Head-to-pelvis Computed Tomography Evaluation of Sudden Death Survivors

NCT03111043
COMPLETED

Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals

NCT02621242
COMPLETED NA

Collaborative Perinatal Mental Health and Parenting Support in Primary Care

NCT02724774
COMPLETED Phase 1

Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma

NCT02541565
COMPLETED Phase 1

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

NCT02451553
COMPLETED NA

Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management

NCT02608177
COMPLETED Phase 1

"Pharmacokinetic Study of Nicotinamide Riboside"

NCT02689882
COMPLETED NA

Chronic Pain Skills Study

NCT02653664
COMPLETED Phase 1

Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

NCT02538510
COMPLETED NA

A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity

NCT02655354
COMPLETED NA

Virtual Reality Water Friendly Wound Care

NCT02646787
COMPLETED

Biological Determinants of Peritoneal Dialysis

NCT02694068
COMPLETED NA

High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

NCT02551718
COMPLETED

Quantifying Patient-Specific Changes in Neuromuscular Control in Cerebral Palsy

NCT02699554
COMPLETED Phase 2

Lactobacillus Probiotic for Prevention of UTI

NCT03151967
COMPLETED

Topical Antibiotic Treatment for Spine Surgical Site Infection

NCT02776774
← Previous Page 12 of 21 Next →

Phase Distribution

PhaseTrial count
Phase 1 127
Phase 2 193
Phase 3 39
Phase 4 65

Therapeutic Areas

Depression 13
Chronic Pain 9
Dementia 8
Multiple Sclerosis 8
Post Traumatic Stress Disorder 7
Stage IV Breast Cancer 6
Pain 6
Anatomic Stage IV Breast Cancer AJCC v8 6
Anatomic Stage III Breast Cancer AJCC v8 6
Spinal Cord Injuries 6

What is open in the University of Washington pipeline

156 recruiting of 1,048 indexed (15% open); 720 completed (69%).

Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).

Top condition: Depression (13 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Washington: open-pipeline peers nationwide

Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 6%8%10%12%14%16% Total trials Recruiting share University of WashingtonUniversity of Wisconsin, MadisonBristol-Myers SquibbUniversity of FloridaUniversity of North Carolina, Chapel HillDompé Farmaceutici S.p.AVanderbilt-Ingram Cancer CenterArizona State UniversityGeorgetown University
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,048 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Washington page

1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.

  • 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.